Patients with rheumatoid arthritis are at an increased risk for venous thromboembolism, regardless of age, sex, BMI, and ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

A team of scientists from Japan has identified hidden immune ‘hubs’ that drive joint damage in patients with rheumatoid ...

Rheumatoid arthritis (RA) can make working difficult. Depending on how severely RA affects your ability to work, it can be ...

SaveHealth reports arthritis affects millions, involving joint inflammation and pain. Various types exist, with treatment ...

From having grinding sensations in the hip joint to experiencing pain the hip and groin, here are the early signs of hip arthritis to watch out for.

BOSTON & SAN FRANCISCO, August 21, 2025--(BUSINESS WIRE)--OM1, a leader in real-world evidence (RWE) generation and AI-driven ...

The study tests three interventions: Lutikizumab monotherapy, Ravagalimab monotherapy, and a combination of both, against placebos. These drugs are administered via subcutaneous injections and aim to ...

Having multiple chronic conditions may signal higher odds of disease flare and lower odds of achieving remission in patients ...

The team from Kyoto University discovered that peripheral helper T cells (Tph cells) -- a key type of immune cell involved in ...

A cross-sectional study of RA patients in India finds 34.5% suffer from methotrexate intolerance, with symptoms often ...